Trial Profile
K-115 clinical pharmacology study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Ripasudil (Primary)
- Indications Diabetic macular oedema; Diabetic retinopathy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa Pharmaceutical
- 07 Jun 2016 New trial record